Variables | BCR-free survival | ||
---|---|---|---|
Exp (B) | 95% CI | P | |
Age (<70 vs. ≥70) | 2.68 | 0.17–5.03 | NS |
Preoperative PSA (<10 ng/mL vs. ≥10 ng/mL) | 2.34 | 0.11–4.48 | NS |
Gleason score (4–6 vs. 7–10) | 2.26 | 0.10–4.32 | NS |
Pathological stage (T1-2 vs. T3-4) | 5.61 | 1.12–11.28 | <0.001 |
Lymph node metastasis (Negative vs. Positive) | 4.13 | 0.82–8.22 | 0.002 |
Angiolymphatic invasion (Negative vs. Positive) | 5.62 | 1.12–11.39 | <0.001 |
Surgical margin status (Negative vs. Positive) | 2.27 | 0.10–4.82 | NS |
miR-126 expression (High vs. Low) | 5.68 | 1.19–11.33 | <0.001 |